X-ray tomography and 3D EBSD help researchers better understand the formation of complex microstructures through crystallization The complex pathway by which metals and alloys form solids via crystallization is still not fully understood by the scientists and engineers who have studied these materials for decades. Dr. Ashwin Shahani and his group at the University of... Read more
This article is translated from press release in Japanese for your convenience. Forward-Looking Statements Statements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based on the conclusions of management... Read more
Thermo Fisher Scientific’s Support of COVID-19 Response Continues to Expand with U.S. Government Contract for Products Used in Sample Collection WALTHAM, Mass., May 18, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced it has received a contract from the U.S. government to provide highly specialized viral transport... Read more
Phase II CITYSCAPE trial shows promising results adding tiragolumab to Tecentriq in people with PD-L1-positive metastatic non-small cell lung cancer Full results will be presented in an oral abstract session at the ASCO20 Virtual Scientific Program organised by the American Society of Clinical Oncology (ASCO) Basel, 14 May 2020 – Roche (SIX: RO, ROG; OTCQX:... Read more
FRANKLIN LAKES, N.J., May 7, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $4.253 billion for the second fiscal quarter ended March 31, 2020. This represents an increase of 1.4 percent as reported over the prior-year period, or 2.4 percent on a currency-neutral... Read more
WASHINGTON, May 6, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the quarter ended April 3, 2020. All results in this release reflect only continuing operations unless otherwise noted. For the first quarter 2020, net earnings were $595.1 million, or $0.81 per diluted common share. Non-GAAP adjusted diluted net earnings... Read more
RAINER M. BLAIR TO SUCCEED THOMAS P. JOYCE, JR. AS PRESIDENT AND CEO IN SEPTEMBER 2020 WASHINGTON, May 6, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) today announced that Executive Vice President, Rainer M. Blair, will succeed Thomas P. Joyce Jr. as President and Chief Executive Officer and as a member... Read more
Revenue of $652.4 million; 1% reported growth; (1)% organic growth GAAP EPS from continuing operations of $0.30; Adjusted EPS of $0.67 Withdrawing previously disseminated FY20 guidance due to COVID-related uncertainties WALTHAM, Mass.–(BUSINESS WIRE)–May 5, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–May 5, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that the U.S. Food and Drug Administration (FDA) has provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company) Anti-SARS-CoV-2 ELISA (IgG) serology test. Clinical laboratories certified to perform high complexity tests under Clinical... Read more
Reported net income of $38 million or $0.21 per share; adjusted net income of $42 million or $0.23 per share Organic revenue declined 8% in the first quarter, impacted by COVID-19; declined 9% on a reported basis Maintaining strong balance sheet, ~$1.7 billion of available liquidity RYE BROOK, N.Y.–(BUSINESS WIRE)–May 5, 2020– Xylem Inc. (NYSE:... Read more